OBrien M, Chalker J, Slade L, Gardiner D, Mailloux RJ
See how Meto providers approach peptide therapy
the combination monitoring device opportunity here is significant, adherence tracking through pill dispensers with embedded sensors is already being spec'd by a few hardware teams The approval of Foundayo marks a pivotal shift in the metabolic landscape, as moving from weekly injections to a once-daily oral pill dismantles one of the largest patient barriers to long-term obesity management
While we cant promise it for everyone, many patients lose enough weight to drastically reduce or eliminate their need for blood pressure medication
GLP-1 therapy has been shown to reduce markers of inflammation, which protects the heart and overall vascular system
Trust me, youll be hooked too